Is a low LDL to HDL ratio good?

A low LDL to HDL ratio is generally good for heart health, with ratios below 2.5 considered optimal. However, the ratio alone doesn't tell the whole story—absolute values of each cholesterol type and other cardiovascular markers matter too.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the LDL to HDL Ratio

The LDL to HDL ratio is a key indicator of cardiovascular health that compares your levels of "bad" cholesterol (LDL) to "good" cholesterol (HDL). This ratio provides valuable insights into your heart disease risk beyond what individual cholesterol numbers can tell you alone.

To calculate your LDL to HDL ratio, simply divide your LDL cholesterol level by your HDL cholesterol level. For example, if your LDL is 100 mg/dL and your HDL is 50 mg/dL, your ratio would be 2.0. Understanding this ratio helps paint a more complete picture of your cardiovascular health status.

Why This Ratio Matters

The LDL to HDL ratio matters because it reflects the balance between cholesterol being deposited in your arteries (LDL) and cholesterol being removed from them (HDL). A lower ratio indicates that you have proportionally more HDL working to clear cholesterol from your bloodstream, which is protective against heart disease.

LDL to HDL Ratio Risk Categories

Ratio RangeRisk CategoryCardiovascular RiskRecommended Action
Below 2.0Below 2.0OptimalVery LowMaintain healthy habits
2.0-2.52.0-2.5GoodLowContinue lifestyle measures
2.5-3.52.5-3.5BorderlineModerateImplement lifestyle changes
Above 3.5Above 3.5High RiskHighConsult healthcare provider

These ranges are general guidelines. Individual risk assessment should consider additional factors including age, gender, and other health conditions.

Research shows that people with lower LDL to HDL ratios have significantly reduced risk of cardiovascular events, including heart attacks and strokes. This is because HDL cholesterol actively removes excess cholesterol from arterial walls, counteracting the harmful effects of LDL accumulation.

What's Considered a Good LDL to HDL Ratio?

Understanding what constitutes a healthy LDL to HDL ratio can help you assess your cardiovascular risk and set appropriate health goals.

Generally, a lower LDL to HDL ratio is better for your health. Most cardiovascular experts agree that ratios below 2.5 are considered optimal, while ratios above 3.5 indicate increased cardiovascular risk. However, these guidelines can vary slightly based on individual risk factors and overall health status.

Gender Differences in Optimal Ratios

It's important to note that optimal ratios can differ between men and women. Women typically have higher HDL levels than men, which often results in lower LDL to HDL ratios. Premenopausal women usually have ratios around 1.5-2.0, while men typically have ratios closer to 2.5-3.0.

After menopause, women's HDL levels often decrease while LDL levels increase, causing their ratios to become more similar to those of men. This shift partly explains why cardiovascular disease risk increases in postmenopausal women.

The Benefits of a Low LDL to HDL Ratio

A low LDL to HDL ratio offers numerous cardiovascular benefits. People with lower ratios have reduced arterial plaque formation, better blood flow, and decreased inflammation in blood vessels. These factors combine to significantly lower the risk of heart attacks, strokes, and other cardiovascular events.

Beyond cardiovascular protection, a favorable cholesterol ratio is associated with better metabolic health overall. Studies have linked lower LDL to HDL ratios with improved insulin sensitivity, reduced risk of metabolic syndrome, and better cognitive function as we age.

Long-term Health Implications

Maintaining a low LDL to HDL ratio throughout life can have profound effects on longevity and quality of life. Research indicates that people who maintain optimal ratios have up to 50% lower risk of developing cardiovascular disease compared to those with high ratios.

The protective effects extend beyond the heart. A healthy cholesterol ratio is associated with reduced risk of peripheral artery disease, better kidney function, and potentially lower risk of certain types of dementia linked to vascular health.

When a Low Ratio Might Not Tell the Whole Story

While a low LDL to HDL ratio is generally positive, it's crucial to consider the absolute values of each cholesterol type. For instance, if both your LDL and HDL are very low, you might have a good ratio but still face health concerns. Extremely low cholesterol levels can be associated with hormonal imbalances, nutritional deficiencies, or other health issues.

Additionally, the LDL to HDL ratio doesn't capture all aspects of cardiovascular risk. Other important factors include triglyceride levels, blood pressure, inflammation markers like high-sensitivity C-reactive protein (hs-CRP), and advanced lipid markers like apolipoprotein B (ApoB). For a comprehensive cardiovascular risk assessment, consider getting a complete lipid panel that includes these additional markers.

The Role of Particle Size and Number

Not all LDL particles are created equal. Small, dense LDL particles are more atherogenic (likely to cause arterial plaque) than large, fluffy LDL particles. Similarly, the total number of LDL particles (measured by ApoB) may be a better predictor of cardiovascular risk than LDL cholesterol concentration alone.

This is why some people with seemingly good LDL to HDL ratios still develop cardiovascular disease. Advanced lipid testing that measures particle size and number can provide additional insights beyond the standard cholesterol panel.

How to Improve Your LDL to HDL Ratio

Improving your LDL to HDL ratio involves both lowering LDL cholesterol and raising HDL cholesterol. The most effective approach combines dietary changes, regular physical activity, and lifestyle modifications. Here are evidence-based strategies to optimize your ratio:

Dietary Strategies

  • Increase soluble fiber intake from oats, beans, lentils, and fruits
  • Replace saturated fats with monounsaturated fats from olive oil, avocados, and nuts
  • Add omega-3 fatty acids from fatty fish, walnuts, and flaxseeds
  • Limit trans fats and processed foods
  • Include plant sterols and stanols from fortified foods or supplements
  • Moderate alcohol consumption (which can raise HDL in some people)

Exercise and Lifestyle Changes

Regular aerobic exercise is one of the most effective ways to raise HDL cholesterol while lowering LDL. Aim for at least 150 minutes of moderate-intensity exercise or 75 minutes of vigorous exercise weekly. High-intensity interval training (HIIT) has shown particular promise for improving cholesterol ratios.

Other lifestyle factors that can improve your ratio include maintaining a healthy weight, quitting smoking (which can raise HDL by up to 10%), managing stress through meditation or yoga, and getting adequate sleep. Even modest weight loss of 5-10% can significantly improve your cholesterol profile.

Monitoring Your Cholesterol Ratio Over Time

Regular monitoring of your cholesterol levels is essential for tracking progress and adjusting your health strategies. Most adults should have their cholesterol checked at least every 4-6 years, but those with risk factors or existing cardiovascular conditions may need more frequent testing.

When monitoring your cholesterol, look for trends rather than focusing on single measurements. Cholesterol levels can fluctuate based on recent meals, stress, illness, and other factors. Tracking your LDL to HDL ratio over time provides a more reliable picture of your cardiovascular health trajectory.

When to Seek Medical Guidance

While lifestyle modifications can significantly improve cholesterol ratios for many people, some individuals may need medical intervention. Consider consulting with a healthcare provider if your LDL to HDL ratio remains above 3.5 despite lifestyle changes, or if you have additional risk factors like diabetes, hypertension, or a family history of early heart disease.

Your doctor may recommend medications like statins, PCSK9 inhibitors, or other lipid-lowering therapies based on your overall cardiovascular risk profile. Remember that medication works best when combined with healthy lifestyle habits.

The Bottom Line on LDL to HDL Ratios

A low LDL to HDL ratio is indeed good for your health, serving as a strong indicator of cardiovascular protection. Ratios below 2.5 are associated with significantly reduced risk of heart disease, stroke, and other cardiovascular events. However, this ratio is just one piece of the cardiovascular health puzzle.

For optimal health, focus on maintaining both healthy individual cholesterol levels and a favorable ratio through a combination of nutritious eating, regular exercise, stress management, and appropriate medical care when needed. Regular monitoring through comprehensive lipid panels can help you track your progress and make informed decisions about your cardiovascular health.

References

  1. Millán, J., Pintó, X., Muñoz, A., et al. (2009). Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management, 5, 757-765.[PubMed]
  2. Calling, S., Johansson, S. E., Wolff, M., et al. (2021). The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women's health in the Lund area (WHILA): a 17-year follow-up cohort study. BMC Cardiovascular Disorders, 21(1), 183.[PubMed][DOI]
  3. Fernandez, M. L., & Webb, D. (2008). The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. Journal of the American College of Nutrition, 27(1), 1-5.[PubMed]
  4. Arsenault, B. J., Rana, J. S., Stroes, E. S., et al. (2009). Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Journal of the American College of Cardiology, 55(1), 35-41.[PubMed][DOI]
  5. Ridker, P. M., Rifai, N., Cook, N. R., et al. (2005). Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA, 294(3), 326-333.[PubMed]
  6. Lemieux, I., Lamarche, B., Couillard, C., et al. (2001). Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Archives of Internal Medicine, 161(22), 2685-2692.[PubMed]

Was this article helpful?

Frequently Asked Questions

How can I test my LDL to HDL ratio at home?

You can test your LDL to HDL ratio at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive cholesterol testing including LDL, HDL, total cholesterol, and advanced markers like ApoB. The program provides lab-quality results and personalized insights delivered to your smartphone.

What is the ideal LDL to HDL ratio for women vs men?

For women, the ideal LDL to HDL ratio is typically 1.5-2.0, while for men it's 2.0-2.5. Women naturally tend to have higher HDL levels, resulting in lower ratios. However, these ratios can change with age, particularly after menopause when women's ratios often increase.

Can you have too low of an LDL to HDL ratio?

While a low ratio is generally good, extremely low ratios (below 1.0) might indicate very low cholesterol levels overall, which can be associated with hormonal imbalances, malnutrition, or other health issues. It's important to consider absolute cholesterol values, not just the ratio.

How quickly can I improve my LDL to HDL ratio?

With dedicated lifestyle changes, you can see improvements in your cholesterol ratio within 6-12 weeks. HDL levels typically respond more slowly than LDL, sometimes taking 2-3 months to show significant changes. Regular exercise and dietary modifications tend to produce the fastest results.

Is the LDL to HDL ratio more important than total cholesterol?

The LDL to HDL ratio is often more predictive of cardiovascular risk than total cholesterol alone. However, both measurements provide valuable information. The most comprehensive assessment includes the ratio, individual cholesterol values, and advanced markers like ApoB and triglycerides.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details